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Hand osteoarthritis (HOA) is a prevalent condition for which treatments are based on analgesia and physical therapies. Our
primary objective was to evaluate pain perception in participants with HOA by assessing the characteristics of nodal involvement,
pain threshold in each hand joint, and radiological severity. We hypothesised that inflammation in hand osteoarthritis joints
enhances sensitivity and firing of peripheral nociceptors, thereby causing chronic pain. Participants with proximal and distal
interphalangeal (PIP and DIP) joint HOA and non-OA controls were recruited. Clinical parameters of joint involvement
were measured including clinical nodes, VAS (visual analogue score) for pain (0–100mm scale), HAQ (health assessment
questionnaire), and Kellgren-Lawrence scores for radiological severity and pain threshold measurement were performed. The
mean VAS in HOA participants was 59.3mm± 8.19 compared with 4.0mm± 1.89 in the control group (P < 0.0001). Quantitative
sensory testing (QST) demonstrated lower pain thresholds in DIP/PIP joints and other subgroups in the OA group including the
thumb, metacarpophalangeal (MCPs), joints, and wrists (P < 0.008) but not in controls (P = 0.348). Our data demonstrate that
HOA subjects are sensitised to pain due to increased firing of peripheral nociceptors. Future work to evaluate mechanisms of
peripheral sensitisation warrants further investigation.
1. Introduction
Osteoarthritis (OA) is the commonest form of arthritis
worldwide, aﬀecting increasing numbers of people in an
ageing population [1]. Among US adults, nearly 27 million
people have osteoarthritis [2]. The US Framingham study
found that 27% of adults aged over 26 have hand OA (HOA)
[2]. In a European study of 7983 people, 25% of participants
with hand pain showed significant hand disability [3].
Chronic pain, particularly in the functional context of the
hand, causes significant emotional and financial burden to
those aﬀected, impacting on carers and on society as a whole.
Treatment of HOA currently comprises analgesia with parac-
etamol, nonsteroidal anti-inflammatory drugs (NSAIDs),
opioid analgesics, and rehabilitative hand physiotherapy [4].
However, large numbers of people continue to experience
impaired hand function and pain. There is therefore a
pressing unmet need to improve management of HOA.
Recent work has focused on aiming to understand
mechanisms of pain in OA [5]. Previous studies have
shown subchondral inflammation and neoinnervation at
the local joint level, which is accompanied by vascular
invasion in the subchondral plate in the OA joint [6].
In addition, modification of neural networks may occur
during OA, which reflects long-term changes in expression of
neurotransmitters, their receptors, and neural ion channels.
These processes contribute to altered pain perception, also
known as sensitisation [5]. Although several well-validated
pain outcome measures are in use in clinical practice, for
example, the Western Ontario and McMaster Universities
Arthritis Index (WOMAC) and visual analogue score for pain
(VAS), amajor issue in OA is how to quantify pain objectively
in patients. Several groups have recently reported the use of
quantitative sensory testing (QST) [7, 8]. Pain threshold test-
ing using algometers has become more widely accepted for
measuring pain perception objectively since it demonstrates
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low variability over time in people with knee OA [7] or
intraoral pain [8]. Recently, Suokas et al. published a meta-
analysis showing that quantitative sensory testing of pain
pressure thresholds demonstrated good reproducibility in
diﬀerentiating between people with OA and healthy controls
[9]. In their meta-analysis, Suokas et al. found that pain pres-
sure threshold testing in OA-aﬀected sites suggested periph-
eral sensitisation and central sensitisation in remote sites [9].
The primary aim of our study was to evaluate pain
perception in a cohort of participants with hand OA by
assessing the characteristics of nodal involvement, pain
thresholds in both hands, and radiological severity. The
secondary aim of our study was to evaluate any features
of sensitisation in our cohort of subjects with hand OA
compared with healthy non-OA controls.
2. Methods
2.1. Participants. The London-Surrey Borders Research
Ethics Committee provided ethical approval for this study,
reference 09/H0718/60. Thirteen participants with hand OA
were recruited from rheumatology outpatient clinics at St
George’s Hospital, London. All participants had hand pain
due to primary OA of DIP (distal interphalangeal joints)
and PIP (proximal interphalangeal) joints. Inclusion criteria
were age range 40–85, female gender, and fulfilling ACR
clinical criteria for HOA [10]. Exclusion criteria included
another rheumatological diagnosis, for example, rheumatoid
arthritis, recent surgery, male gender, diabetes mellitus,
psychiatric disorders, and other neurologic conditions. Sec-
ondary OA (posttraumatic, metabolic, and inflammatory
rheumatic disease) patients were also excluded. Healthy
controls were recruited through poster advertisements at St
George’s Hospital and St George’s University of London. The
absence of hand OA was checked in this population by a
clinical history and examination by two qualified rheuma-
tologists (J. Wajed/N. Sofat). The same exclusion criteria as
for the OA group were applied. The controls were matched
for gender, age range, no other comorbidities including
ischaemic heart disease, psychiatric disorders, and diabetes
mellitus. Thirteen female controls were recruited through
poster advertisements. This study was limited to females due
to recognised gender diﬀerences in pain perception [11, 12].
A homogeneous cohort of female HOA participants and
controls was therefore recruited.
2.2. Clinical Evaluation. A number of self-administered
questionnaires were completed including the Visual Ana-
logue Score (VAS) for pain (0–100mm) [13], for which par-
ticipants were asked their average pain score in their hands
in the previous week, the Health Assessment Questionnaire
(HAQ) [14], and the Hospital Anxiety and Depression Scale
(HADs) [15]. Use of analgesic drugs by the HOA group
and controls was recorded (Figure 1). All HOA participants
underwent plain radiography of both hands using standard-
ised views. Kellgren-Lawrence scores (K-L) [16] were agreed
by consensus opinion of two senior musculoskeletal radiolo-
gists (V. Ejindu and C. Heron). A radiographic training atlas
Oral NSAID (6/13, 46.1%)
Paracetamol (5/13, 38.5%)
Oral NSAID and opiate (1/13, 7.7%) 
Topical NSAID (1/13, 7.7%)
Figure 1: Hand OA participant analgesic use. The subgroups with
respect to analgesic use in the hand OA group were classified
as (1) oral NSAID including diclofenac, ibuprofen, or celecoxib;
(2) paracetamol up to 1 g four times daily; (3) oral NSAID
(diclofenac) plus opiate (cocodamol); (4) topical NSAID (ibuleve
gel). Proportions of participants in each group are shown in
addition to percentages.
for OA [17] was used and before the scoring, each consultant
radiologist also underwent a training session. K-L scores for
each individual hand joint: thumb carpometacarpal (CMC),
metacarpophalangeal (MCP), and interphalangeal (IP) joints
and all MCPs, PIPs, and DIPs) were recorded at each joint
specified in the range 0–4 using standard criteria [17]. This
allowed K-L scores for individual joints to be related to
algometer scores for each jointmeasured. A hand-held digital
algometer (Wagner Instruments, CT, USA) was used to test
pain threshold in all participants in both hands with n = 30
regions for each participant, 780 regions in total. Regions
tested included dorsal aspects of all DIP, PIP, and MCP joints
of each digit and thumb and the dorsum of each wrist. The
1 cm2 flat rubber algometer probe was held perpendicular to
the dorsal aspect of the skin and force was applied to provide
a constant increase in pressure at a rate of 1 Newton/cm2 per
sec. Therefore, the algometer scores are stated as N/cm2 in all
reported results. The individual was asked to say “stop” when
the sensation of pressure became the first sensation of pain.
The algometer was applied by each joint being examined 3
times in succession with an interval between applications.
After all three readings were taken, the average from the last
2 readings was calculated as the pain pressure threshold. The
intervals between each algometer measurement were long
enough to prohibit temporal summation (TS). Temporal
summation occurs when a series of nerve impulses arrives
at a synapse so that the duration of the impulses is shorter
than the postsynaptic potential, thereby meaning that the
delivery of transmitted impulses is combined to create a
larger than normal impulse [18]. This phenomenon has also
been described as temporal summation of “second pain”
(TSSP) or “windup,” which results from the summation of
C-fibre-evoked responses of dorsal horn neurons [19]. The
QST involved taking 3 readings from 15 joints in both hands,
that is, 45 readings from a relatively small anatomical area.
Since the pain pressure thresholds in the joints being tested
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Table 1: Group demographics. The age (mean ± SD), family history of OA, comorbidity, and information on previous joint replacement
surgery in the hand OA and control groups are shown.
Characteristic
OA group
Mean ± SD
Control group
Mean ± SD P value
Age 61.0 ± 13.7 52.8 ± 5.3 P = 0.12
Family history of OA 11/13 2/13 —
Knee: 7/13
Foot/ankle: 5/13
OA involvement in other joints Spine: 1/13 — —
Shoulder: 1/13
Hip: 1/13
Comorbidity
(1) Hypertension 2/13 2/13
(2) Hypothyroidism 0/13 2/13
(3) Breast cancer 2/13 0/13 —
(4) Dyspepsia 1/13 1/13
(5) Intervertebral disc herniation 0/13 1/13
Previous surgery
Total hip
replacement: 1/13
— —
were in close proximity, the QST protocol was designed,
so that pressure was applied over the bony surfaces of the
dorsal aspects of the joints aﬀected. In addition, where the
joints were in very close proximity, that is, the knuckles,
typically the following order was taken when measuring pain
thresholds: 1st CMC, 3rd MCP, 5th MCP, 2nd MCP, 4th
MCP, and so on. Previous studies have suggested an induc-
tion of temporal summation at 0.33Hz in participants with
musculoskeletal pain [19]. In our study, we allowed a variable
pause between 1 and 5 seconds between each application of
pain pressure threshold testing in order to avoid eﬀects of
temporal summation in our HOA and control groups.
2.3. Statistics. All clinical data was analysed using Graphpad
Prism (CA, USA). Data was expressed as mean ± standard
deviation unless otherwise stated. For correlation analyses,
Spearman rank correlations were performed with a 95%
confidence interval and two-tailed P values. Assessment
of agreement of kappa scores between the two consultant
radiologists was performed using an online kappa calcu-
lator http://justusrandolph.net/kappa/ and has been well-
validated [20] in previous studies. For comparing group
means, the Mann-Whitney U statistical test for comparison
of nonparametric data was used. For comparing if values
in pain thresholds varied between diﬀerent subgroups, the
Kruskal-Wallis test was used. Significance was considered to
be at P ≤ 0.05 in all analyses.
3. Results
3.1. Hand OA Participants Have Higher VAS Scores and
Significant Functional Impairment Compared to Controls.
For the HOA group, mean age was 61.0 ± 3.79, and the
control group was slightly younger with a mean age 52.8
± 1.47, with no statistically significant diﬀerence in age
between the two groups (P = 0.12) (Table 1). All hand OA
participants had a family history of OA with involvement
at other sites including the knee, hip, shoulder, ankle,
and spine (Table 1). The two groups were well matched
with respect to comorbidities, which included hypertension,
hypothyroidism, carcinoma of the breast, dyspepsia and
intervertebral disc disease. Only 1 participant in the hand OA
group had previous joint replacement surgery of the hip.
All participants were female, with a mean duration of
diagnosis for the hand OA group of 6.1 years (SD 1.19)
(Table 2). VAS, HAQ, and HADS scores were significantly
diﬀerent between groups (Table 2). The HOA group reported
significantly high pain scores with a mean VAS of 59.3± 8.19
compared with controls of 4.0± 1.89 (P < 0.0001). The HOA
group demonstrated significant functional impairment, with
HAQ scores 8-fold higher than controls (P < 0.0001). When
considering HADS scores for anxiety and depression, HOA
participants had significantly higher values on anxiety scales
(P < 0.01) and depression scales (P < 0.05) than controls.
This finding suggests that HOA subjects may anticipate
higher anxiety while considering performing functional tasks
with their hands. It is also notable that although the HOA
participants did report higher anxiety levels, they did not
reach clinical diagnostic levels of anxiety and depression.
From Tables 1 and 2, one can observe that the control group
is slightly younger, diﬀering by an average of 8 years. Due
to such age diﬀerences, it is possible that age could have
had an eﬀect on reporting of anxiety and depression and
pain thresholds. It was also observed that the hand OA and
healthy control groups were all right-handed and had similar
occupational demographics with predominantly sedentary
occupations (Table 3). In the hand OA group all subjects
had symptoms of pain in both hands, suggesting that lifting
or carrying heavy objects, or handedness, was not involved
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Table 2: Participant-reported outcome measures (PROMs). Data
for duration of diagnosis, VAS in the hand OA versus the
control group, Hospital Anxiety and Depression Scale (HADs)
with subscales for anxiety and depression, and Health Assessment
Questionnaire (HAQ) scores are shown with mean ± SD. P values
are shown for group comparisons between hand OA and healthy
control participants. Diﬀerences between groups were analysed
using the Mann-Whitney U-test with significance considered at
P ≤ 0.05.
Demographic OA group
Normal
group
P value
Duration of diagnosis (y) 6.1 ± 1.19 n/a n/a
VAS score (mm) mean 59.3 ± 8.19 4.0 ± 1.89 <0.0001∗
HADS depression score 3.2 ± 2.34 1.5 ± 1.66 0.05∗
HADS anxiety score 7.5 ± 3.93 3.7 ± 3.20 0.01∗
HAQ score 0.8 ± 0.10 0.11 ± 0.08 <0.0001∗
Statistically significant values are marked on the table with∗.
in the development of their symptoms. There was a much
higher preponderance for a family history of OA in the hand
OA group than the healthy controls with similar levels of
comorbidity in both groups.
All hand OA participants were taking analgesics, with
92% on oral analgesic drugs (Figure 1). Figure 1 illustrates
the variety of prescribed analgesics utilised by the hand OA
cohort including paracetamol use alone (5/13, 38.5%), oral
NSAID use (including ibuprofen, diclofenac, and celecoxib)
(6/13, 46.1%), oral NSAID and opiate use (1/13, 7.7%), and
topical NSAID use (1/13, 7.7%). No controls were taking
regular analgesic medication. Of the hand OA participants,
many had severe symptomatic complaints reflected by the
observation that 92% required oral analgesic drugs. Of the
hand OA group, 69.2% had involvement in other joints
including the spine, knee, hip, and ankles.
3.2. Pain Thresholds Are Reduced in Hand Joints of OA
Participants Compared with Controls. The evaluation of pain
thresholds in our study demonstrated that HOA participants
showed significantly lower algometer scores (mean 23.5, SD
11.9 Newtons) than controls (mean 34.1, SD 13.8N/cm2,
P < 0.0001) (Figure 2(a)). In a subgroup analysis of mean
pain thresholds in the wrist, thumb 1st CMC/IP, MCPs, PIPs,
and DIPs, Figures 2(b) and 2(c) show that pain thresholds
did not vary significantly between diﬀerent subgroups in the
control group (P = 0.34). In contrast, there was a statistically
significant diﬀerence in subgroups between the subgroups
assessed in the hand OA group, with pain thresholds in
the thumb 1st CMC/IP, MCPs, PIPs, and DIPs varying
significantly with the wrist (P = 0.008).
We next evaluated the relation between clinical nodes,
radiographic grade, and pain thresholds. The proportion of
palpable nodes in the HOA cohort was 49% (191/390), all of
which were in the PIP/DIP joints. Of all the joints assessed,
the percentage of hand joints with K-L grade ≥ 2 was 49.2%
(192/390). There was no significant correlation between
pain thresholds and participant-reported VAS scores in the
hand OA group (P = 0.094, r value = −0.484) (Figure 3),
indicating that VAS scores and pain thresholds may be testing
distinct components of pain perception. In the joints most
severely aﬀected both clinically and radiographically, that
is, the PIP and DIP joints, increasing radiological severity
was associated with a significantly lower pain threshold
(Figure 4). The same relationship was not observed in the
thumb 1st CMC/IP or MCP joints in the hand OA group
(Figure 4). In the wrist, the proportion of subjects with K-
L score 0–2 was 21/26 and K-L score 3-4 was 5/26. Data in
Figure 2(b) demonstrate that the mean pain thresholds were
higher in the wrist than other subgroups in the hand OA
group (mean 29.5 ± SEM 3.0), but that the hand OA group
had a lower mean pain threshold at the wrist than the control
wrist group (mean 40.4 ± SEM 3.1).
The agreement between observers (two consultant radi-
ologists VE and CH) for the Kellgren-Lawrence grading was
calculated using a kappa score calculation. This showed that
the percent overall agreement was 0.769 with a fixedmarginal
kappa of 0.257 and a free marginal kappa of 0.538, suggesting
good agreement of K-L grading between the two observers
[20].
4. Discussion
Our study is the first to demonstrate that subjects with nodal
HOA have reduced pain thresholds in their finger and wrist
joints compared with non-HOA controls, suggesting that
in chronic HOA people are sensitised to pain. Since non-
DIP/PIP finger and wrist joints with low K-L scores for
radiological severity also demonstrated reduced pain thresh-
olds in our HOA group, our work suggests that participants
with HOA have evidence of peripheral sensitisation. Our
work is in agreement with other investigators who have
demonstrated features of peripheral sensitisation in OA of
the knee [7] and hip [21].
HOA is a chronic disease in which mechanisms of
pain are not fully understood. Our study has shown that
our cohort of HOA participants has significant functional
impairment with mean HAQ scores of 0.8 which are similar
to patients with established RA [22] and erosive HOA [23].
The significant functional impairment in our group was
associated with evidence of hyperalgesia globally in finger
and wrist joints (in participants with mainly DIP and PIP
joint disease), demonstrating reduced pain thresholds across
all finger and hand joints by algometer testing. Although we
observed a strong correlation between increasing radiological
severity and lower pain threshold in the PIP and DIP joints,
globally reduced pain thresholds were observed in the hand
including thumb and MCP joints that did not correlate
with radiological severity. Our data also agrees with previous
observations of lowered pain thresholds and hyperalgesia to
mechanical stimuli in OA joints [24].
Limitations of our study include that we analysed a
relatively small number of participants, that is, n = 26 in
total. The HOA participants in this study were recruited
from a specialist rheumatology clinic and therefore were
likely to have more severe hand OA since they had been
referred by primary care. The majority of our participants
International Journal of Rheumatology 5
Hand OA Normal
0
25
50
75
A
lg
om
et
er
 (
N
/c
m
2
)
P < 0.0001
(a)
Hand joint
0
10
20
30
40
50
HOA group
Control group
A
lg
om
et
er
 (
N
/c
m
2
)
MCP PIP DIPWrist Thumb
IP/CMC
(b)
Group
Kruskal-
Wallis
test
P value Number of groups
Kruskal-
Wallis
statistic
Hand
Osteoarthritis
0.008 Significant 5 13.81
Control group 0.348
Not 
significant 5 4.45
(c)
Figure 2: Pain threshold analysis in hand OA and control group. (a) Plot of algometer scores in Newtons per square cm (N/cm2) for a total
of 780 joints in the hand OA participants and controls is shown. Each point represents one hand joint region algometer score with mean
values indicated by the solid line. (b) Subgroup analysis of data in hand OA and control groups stratified according to joint region involved.
The 5 subgroups include wrist, thumb 1st CMC/IP, MCPs, PIPs, and DIPs. Data plotted are mean ± SEM. SEM was used to account for
the varying number of joints between diﬀerent groups (c). Statistical comparison between groups is shown in (b). The Kruskal-Wallis test
was used to evaluate statistical significance between the subgroups within the hand OA and control groups. A significant diﬀerence between
groups was considered at P ≤ 0.05.
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Figure 3: Correlation analysis between VAS and algometer scores. A correlation plot for hand OA participants between VAS scores (mean
± SD) and algometer scores is shown. Spearman correlation analysis for statistical significance is shown. A significant diﬀerence between
groups was considered at P ≤ 0.05.
6 International Journal of Rheumatology
PIP/DIP joints
0-1 2 3 4
0
25
50
75
K-L score
A
lg
om
et
er
 (
N
/c
m
2
)
PIP/DIP
0-1 versus 2 0.02
0-1 versus 3 0.002
P value
0-1 versus 4 <0.001
(a)
Thumb CMC/IPJ
0-1 2 3 4
K-L score
0
25
50
75
A
lg
om
et
er
 (
N
/c
m
2
)
CMC/IPJ
0-1 versus 2 0.11
0-1 versus 3 0.27
P value
0-1 versus 4 0.057
(b)
MCP joints
0-1 2 3 4
K-L score
0
25
50
75
A
lg
om
et
er
 (
N
/c
m
2
)
MCP 
0-1 versus 2 0.48
P value
(c)
Figure 4: Comparison of pain pressure thresholds by algometer testing with Kellgren-Lawrence score by joint distribution in the hand OA
cohort. Algometer versus K-L scores are also shown in DIP/PIP joints (a), thumb IP joints (b), and MCP joints (c). Diﬀerences between
groups were analysed using an unpaired t-test (significance considered at P ≤ 0.05).
were also taking oral analgesics and could therefore have
altered algometer pain thresholds changes as a result. Nev-
ertheless, our data demonstrates how algometers could be
useful biomarkers in OA pain studies to assess peripheral
sensitisation and potential response to therapies. Recently,
a rodent model of OA showed that treatment with NSAIDs
only showed transient analgesic eﬀects, whereas the eﬀects
of centrally-acting analgesics, including amitriptyline and
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Table 3: Participant cohort demographics. The age, gender, family history of OA, past medical history and concomitant medication in the
hand OA (OA1–OA13), and healthy controls (C1–C13) are shown.
Participant Age Sex Occupation PMH
Other nonanalgesic
medication
Handed
(R or L)
FH of OA
Duration of OA
diagnosis (years)
OA1 57 F Teacher Carcinoma breast Tamoxifen R Y 5
OA2 87 F Retired clerical worker Carcinoma breast Aromatase inhibitor R Y 10
OA3 42 F Cleaner None — R Y 1
OA4 53 F Teacher None — R Y 3
OA5 75 F Retired None — R Y 4
OA6 70 F Lecturer Hypertension Antihypertensive R Y 10
OA7 49 F Legal Assistant None — R N 5
OA8 67 F Writer Dyspepsia Omeprazole R N 1
OA9 54 F Management position None — R Y 8
OA10 71 F Retired teacher None — R Y 15
OA11 41 F
Retired teaching
assistant
None — R Y 5
OA12 71 F Retired librarian Hypertension Antihypertensive R Y 10
OA13 56 F Special needs worker None — R Y 3
C1 52 F Manager
Hypertension
Hypothyroidism
Antihypertensive
Thyroxine
R Y 0
C2 47 F Nurse None — R N 0
C3 63 F Clerical worker None — R N 0
C4 52 F Support worker None — R N 0
C5 55 F Nurse Hypothyroidism Thyroxine R Y 0
C6 46 F Secretary None — R N 0
C7 56 F Receptionist None — R N 0
C8 51 F Clerical worker None — R N 0
C9 55 F Secretary
Hypertension
Dyspepsia
Antihypertensive
Lansoprazole
R N 0
C10 50 F Support worker None — R N 0
C11 57 F Nurse Hypothyroidism Thyroxine R N 0
C12 58 F Nurse Disc protrusion Paracetamol as required R N 0
C13 44 F Nurse None — R N 0
PMH: past medical history, FH: family history.
gabapentin, were more sustained [25]. Of note, none of the
participants in our study were on centrally acting analgesics
or disease-modifying therapy, as demonstrated in Table 2. It
is conceivable that future treatments for pain should include
centrally acting agents for chronic conditions such as hand
OA where no disease-modifying therapies exist.
In conclusion, our study has found that patients with
HOA not only have low pain thresholds in the most severely
aﬀected finger joints, that is, DIP/PIP joints, but also have
reduced pain thresholds globally across all the finger and
wrist joints tested. Higher functional impairment and anxi-
ety were also experienced by ourHOAparticipants compared
with controls, suggesting that people with HOA may be
sensitised to pain in the chronic state. Such considerations
should be taken into account when assessing pain in HOA
in clinical studies and in exploring novel therapeutic options
for pain in HOA.
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